Market Tracker

08/16 5:48pm ET

Eli Lilly and Co (NYSE:LLY)

310.51
Delayed Data
As of Aug 16
 -3.43 / -1.09%
Today’s Change
220.20
Today|||52-Week Range
335.33
+12.41%
Year-to-Date
LLY Regular Dividend: LLY began trading ex-dividend on 08/12/22. A $0.98 dividend will be paid to shareholders of record as of 08/15/22.
Peachtree Investment Partners, LLC Buys 2, Sells 3 in 2nd Quarter
Aug 16 / GuruFocus News - Paid Partner Content
Top 5 2nd Quarter Trades of Mairs and Power
Aug 15 / GuruFocus News - Paid Partner Content
FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. Buys 3, Sells 2 in 2nd Quarter
Aug 16 / GuruFocus News - Paid Partner Content
Eli Lilly's (LLY) Potential New Products Key to Growth
Aug 15 / Zacks.com - Paid Partner Content
This Growth Stock Has Soared Over 200% Year to Date -- Is It a Buy?
Aug 16 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights Eli Lilly, CVS Health, Target, Chipotle Mexican Grill and FirstEnergy
Aug 15 / Zacks.com - Paid Partner Content
Top 5 2nd Quarter Trades of PRINCETON CAPITAL MANAGEMENT LLC
Aug 15 / GuruFocus News - Paid Partner Content
3 Stocks to Buy and Hold Forever
Aug 13 / MotleyFool.com - Paid Partner Content
Top 5 2nd Quarter Trades of Stanley Druckenmiller
Aug 15 / GuruFocus News - Paid Partner Content
L & S Advisors Inc's Top 5 Buys of the 2nd Quarter
Aug 12 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close313.94
Today’s open314.84
Day’s range309.62 - 314.84
Volume2,247,979
Average volume (3 months)2,880,216
Market cap$292.7B
Data as of 4:00pm ET, 08/16/2022

Growth & Valuation

Earnings growth (last year)-9.81%
Earnings growth (this year)-1.79%
Earnings growth (next 5 years)+20.80%
Revenue growth (last year)+15.40%
P/E ratio49.5
Price/Sales8.89
Price/Book32.72

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.13+0.26%
ABBVAbbVie+0.26+0.18%
MRKMerck-0.03-0.03%
AZNAstraZeneca-0.07-0.10%
Data as of 4:00pm ET, 08/16/2022

Financials

Next reporting dateNovember 1, 2022
EPS forecast (this quarter)$1.91
Annual revenue (last year)$28.3B
Annual profit (last year)$5.6B
Net profit margin19.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Indianapolis, Indiana

Forecasts